Fortress Biotech, Inc. Purchase Agreements
10 Contracts & Agreements
- Asset Purchase Agreement, dated as of July 15, 2024, between Urica Therapeutics, Inc. and Crystalys Therapeutics, Inc (Filed With SEC on November 14, 2024)
- Form of Securities Purchase Agreement, dated September 19, 2024, by and among the Company and the purchasers party thereto (Filed With SEC on September 23, 2024)
- Form of Securities Purchase Agreement, dated December 29, 2023, by and among the Company and the purchasers party thereto (Filed With SEC on January 3, 2024)
- Form of Securities Purchase Agreement, dated November 10, 2023, by and among the Company and the purchasers party thereto (Filed With SEC on November 14, 2023)
- Form of Securities Purchase Agreement, dated February 7, 2023, by and among the Company and the purchasers party thereto (Filed With SEC on February 9, 2023)
- Asset Purchase Agreement entered into by and between Journey Medical Corporation and Dermira, Inc. dated as of March 31, 2021 (Filed With SEC on August 16, 2021)
- Asset Purchase Agreement entered into by and between Sentynl Therapeutics, Inc. and Cyprium Therapeutics, Inc. dated as of February 23, 2021 (Filed With SEC on August 16, 2021)
- Asset Purchase Agreement entered into by and between Journey Medical Corporation and Dermira, Inc. dated as of March 31, 2021 (Filed With SEC on May 17, 2021)
- Asset Purchase Agreement entered into by and between Sentynl Therapeutics, Inc. and Cyprium Therapeutics, Inc. dated as of February 23, 2021 (Filed With SEC on May 17, 2021)
- FORM OF SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 5, 2015)
